Bone marrow transplantation: how important is CD34 cell dose in HLA-identical stem cell transplantation?
- 1 May 2003
- journal article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 17 (5), 856-858
- https://doi.org/10.1038/sj.leu.2402893
Abstract
A recent analysis of Fred Hutchinson Cancer Research Center data has been undertaken to investigate the association of infused CD34 cell dose with various clinical outcomes after HLA-identical transplantation. Separate assessments for unrelated vs related donors and the use of bone marrow or mobilized G-CSF stimulated peripheral blood mononuclear cells (G-PBMC) have been incorporated. The three primary findings are: (1) Higher CD34 dose results in better neutrophil and platelet recovery in all settings. (2) Higher CD34 doses (8 x 10(6)/kg) are associated with the development of more chronic graft-versus-host disease when using related G-PBMC. (3) Higher CD34 dose is correlated with improved survival after unrelated donor bone marrow transplantation. These data suggest that the CD34 content of a graft can have a significant impact on clinical outcome after allogeneic transplantation, but defining an optimal dose is dependent on both the type of donor and the stem cell source.Keywords
This publication has 15 references indexed in Scilit:
- Trends in transplantation of hematopoietic stem cells from unrelated donorsCurrent Opinion in Hematology, 2001
- Influence of bone marrow graft lymphocyte subsets on outcome after HLA-identical sibling transplantsExperimental Hematology, 2001
- Comparison of gene expression in CD34+ cells from bone marrow and G-CSF-mobilized peripheral blood by high-density oligonucleotide array analysisTransplantation and Cellular Therapy, 2001
- Genomics of unrelated-donor hematopoietic cell transplantationCurrent Opinion in Immunology, 2001
- Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic CancersNew England Journal of Medicine, 2001
- Cytofluorometric methods for assessing absolute numbers of cell subsets in bloodCytometry, 2000
- Current status of umbilical cord blood hematopoietic stem cell transplantationExperimental Hematology, 2000
- Enumeration of HPC in mobilized peripheral blood with the Sysmex SE9500 predicts final CD34+ cell yield in the apheresis collectionBone Marrow Transplantation, 2000
- Enumeration of CD34-positive hematopoietic progenitor cells by flow cytometry: comparison of a volumetric assay and the ISHAGE gating strategyBone Marrow Transplantation, 1998
- Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cellsCytometry, 1998